Merck’s 23 immune & oncology pipelines accelerated towards commercialization

Published: 2018-05-11 16:26:00
Updated: 2018-05-11 17:20:38

Merck, a global pharmaceutical company, showed a strong will to develop new drugs related to oncology by revealing immune and oncology pipelines being developed by the company.

Professor Morihiro Watanabe taking in charge of the clinical development of Merch Serono introduced the company’s immun...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.